RA
JNCE

Royce & Associates’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Royce & Associates’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,699
Closed -$18K – 1218
2018
Q3 		$18K Buy
2,699
+1,321
+96% +$9.82K ﹤0.01% 1160
2018
Q2 		$11K Buy
+1,378
New +$19.9K ﹤0.01% 1199
2018
Q1 		– Sell
-588
Closed -$7K – 1292
2017
Q4 		$7K Buy
588
+82
+16% +$1.21K ﹤0.01% 1224
2017
Q3 		$8K Buy
+506
New +$7.15K ﹤0.01% 1197

Other funds holding JNCE

TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return